Literature DB >> 21848115

Hyperbaric oxygen therapy improved both pain scores and range of motion in patients with early idiopathic femoral head necrosis (Ficat stage II).

Michael Bennett1.   

Abstract

Entities:  

Year:  2011        PMID： 21848115

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN： 1833-3516            Impact factor:   0.887


× No keyword cloud information.
  6 in total

Review 1.  Clinical effect of hyperbaric oxygen therapy in the treatment of femoral head necrosis : A systematic review and meta-analysis.

Authors:  Wei Li; Ziliang Ye; Wei Wang; Kun Wang; Lang Li; Dewei Zhao
Journal:  Orthopade       Date:  2017-05       Impact factor: 1.087

2.  Vascular endothelial growth factor/bone morphogenetic protein-2 bone marrow combined modification of the mesenchymal stem cells to repair the avascular necrosis of the femoral head.

Authors:  Xiao-Wei Ma; Da-Ping Cui; De-Wei Zhao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Hyperbaric oxygen therapy modulates serum OPG/RANKL in femoral head necrosis patients.

Authors:  Giuliano Vezzani; Silvia Quartesan; Pasqua Cancellara; Enrico Camporesi; Devanand Mangar; Thomas Bernasek; Prachiti Dalvi; Zhongjin Yang; Antonio Paoli; Alex Rizzato; Gerardo Bosco
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

Review 4.  Treatment of non-traumatic avascular necrosis of the femoral head (Review).

Authors:  Ning Liu; Changming Zheng; Qinglong Wang; Zhipeng Huang
Journal:  Exp Ther Med       Date:  2022-03-10       Impact factor: 2.447

5.  Successful Treatment of Lower Limb Complex Regional Pain Syndrome following Three Weeks of Hyperbaric Oxygen Therapy.

Authors:  Rita Katznelson; Shira C Segal; Hance Clarke
Journal:  Pain Res Manag       Date:  2016-03-30       Impact factor: 3.037

Review 6.  Evidence-Supported HBO Therapy in Femoral Head Necrosis: A Systematic Review and Meta-Analysis.

Authors:  Emma Paderno; Vincenzo Zanon; Giuliano Vezzani; Tommaso Antonio Giacon; Thomas L Bernasek; Enrico M Camporesi; Gerardo Bosco
Journal:  Int J Environ Res Public Health       Date:  2021-03-12       Impact factor: 3.390
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.